Discover how a groundbreaking 23-gene risk scoring system is transforming personalized treatment for mucinous colorectal cancer patients.
Explore how cetuximab-conjugated nanoparticles are revolutionizing treatment for triple-negative breast cancer through precision targeting and advanced drug delivery.
Discover how fecal lactoferrin and immunochemical testing are transforming non-invasive diagnosis of colorectal cancer and ulcerative colitis.
Explore how nutrition and biotechnology are transforming the prevention and treatment of heart disease and cancer through molecular mechanisms and personalized medicine.
Discover how microfluidic technology enables non-invasive prostate cancer detection through urine samples without digital rectal examination.
Explore how personalized medicine is transforming healthcare through genomics, proteomics, metabolomics and multi-omics integration for precise diagnosis and treatment.
A breakthrough in nanotechnology using cRGD-PEG iron oxide nanoparticles is revolutionizing cancer detection through targeted MRI imaging.
Explore how polyhydroxyalkanoates (PHAs) are revolutionizing medical applications with their biocompatibility, biodegradability, and tunable properties.
Exploring the revolutionary promise of oncolytic virotherapy for prostate cancer treatment - a precision approach that harnesses viruses to attack cancer cells while awakening immune defenses.
Exploring how ECHELON-1 trial survival benefits translate into significant productivity cost savings for stage III/IV classical Hodgkin lymphoma patients